Aditya Birla SL Pharma & Healthcare Fund(G)-Direct Plan
+13.53%
5Y annualised
+13.53%
5Y annualised
+0.19% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.
NAV : 22 Oct 2026
₹37.51
Min. SIP amount
₹100
Fund size (AUM)
1077 Cr
Expense ratio
1.03%
Launched on
10 Jul 2019
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 22 Oct 2026
₹37.51
Min. SIP amount
₹100
Fund size (AUM)
1077 Cr
Expense ratio
1.03%
Launched on
10 Jul 2019
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
34.68%
Mid Cap
24.56%
Small Cap
37.63%
Others
3.13%
Sector Allocation
Healthcare
89.21%
Domestic Equities
6.66%
Cash & Cash Equivalents And Net Assets
2.06%
Business Services
1.37%
Chemicals
0.69%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
1% on or before 30D, Nil after 30D
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Dhaval Shah
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
ICICI Pru US Bluechip Equity Fund(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
Aditya Birla SL Intl. Equity Fund(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
Quant ESG Integration Strategy Fund(G)-Direct Plan
Motilal Oswal Active Momentum Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.